Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2422618rdf:typepubmed:Citationlld:pubmed
pubmed-article:2422618lifeskim:mentionsumls-concept:C0154841lld:lifeskim
pubmed-article:2422618lifeskim:mentionsumls-concept:C0549122lld:lifeskim
pubmed-article:2422618pubmed:issue3lld:pubmed
pubmed-article:2422618pubmed:dateCreated1986-6-16lld:pubmed
pubmed-article:2422618pubmed:abstractTextIn a prospective study, 120 patients with unilateral central retinal vein occlusion (CRVO) were investigated to determine the role of the relative afferent pupillary defect (RAPD) in differentiating ischemic from nonischemic CRVO. In 87 patients with nonischemic CRVO, 90% had a RAPD 0.3 log units or less and none had a RAPD larger than 0.9 log units. In contrast, in 33 patients with ischemic CRVO 91% had a RAPD of 1.2 log units or more, and none had a RAPD smaller than 0.6 log units. Thus, this simple, quick, and inexpensive test has proved to be a highly sensitive and reliable indicator in the differential diagnosis of the two types of CRVO.lld:pubmed
pubmed-article:2422618pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2422618pubmed:languageenglld:pubmed
pubmed-article:2422618pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2422618pubmed:citationSubsetIMlld:pubmed
pubmed-article:2422618pubmed:statusMEDLINElld:pubmed
pubmed-article:2422618pubmed:monthMarlld:pubmed
pubmed-article:2422618pubmed:issn0161-6420lld:pubmed
pubmed-article:2422618pubmed:authorpubmed-author:HayrehS SSSlld:pubmed
pubmed-article:2422618pubmed:authorpubmed-author:ThompsonH SHSlld:pubmed
pubmed-article:2422618pubmed:authorpubmed-author:ServaisG EGElld:pubmed
pubmed-article:2422618pubmed:issnTypePrintlld:pubmed
pubmed-article:2422618pubmed:volume93lld:pubmed
pubmed-article:2422618pubmed:ownerNLMlld:pubmed
pubmed-article:2422618pubmed:authorsCompleteYlld:pubmed
pubmed-article:2422618pubmed:pagination301-3lld:pubmed
pubmed-article:2422618pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:meshHeadingpubmed-meshheading:2422618-...lld:pubmed
pubmed-article:2422618pubmed:year1986lld:pubmed
pubmed-article:2422618pubmed:articleTitleRelative afferent pupillary defect in central retinal vein occlusion.lld:pubmed
pubmed-article:2422618pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2422618pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2422618pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2422618lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2422618lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2422618lld:pubmed